×

Advanced Systemic Mastocytosis: Considerations to Optimize Patient Management_1

Considerations to Optimize Patient Management

Share with social media

While,advanced systemic mastocytosis (SM) is a rare disorder, treatment options are still available; find out more about management strategies here!

Duration : 01:00:00 hours
Content provider : Akshaya Patra Foundation
Author name :
Matthew P. Giannetti Declaration of interests
Date launched at CMEPEDIA : August 19, 2024
Expiry date of course : November 29, 2025
Module size : 0.82MB
Price : ₹20.97 - ₹3206.55(Prices vary according to your profession and professional body. Log in to see your personalized quote.)
Disclosure information:

 

Medscape, LLC  requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Skill improvements:
knowledge, competence
Topic:
Dermatology, Gastroenterology, Hematology, Immunology, Oncology
Professional category:
Intern/Resident, Physician, Allergist, Gastroenterologist, Hematologist, Immunologist, Oncologist, Specialist in dermatology
Accreditation:
Category Accreditor Credits Accreditation details
Nurse

American Nurses Credentialing Center

 0.25 Nursing Contact Hours In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacist

Accreditation Council for Pharmacy Education

 0.25 ACPE credit In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Hematologist, Oncologist

Accreditation Council for Continuing Medical Education

 0.25 ACCME In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Hematologist, Oncologist

American Board of Internal Medicine

 0.25 MOC Credit Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Endorsements:
Endorsed by Accredited by Conversion credits
Bangalore XYZ council Accreditation Council for Continuing Medical Education 0.25 BXC Credits
Learning outcomes

Upon completion of this activity, participants will:

 

  • Have increased knowledge regarding the
    • Symptoms and diagnostic criteria for types of SM
  • Have greater competence related to
    • Selecting and assessing response to therapies for advanced SM
    • Management of treatment-related adverse effects of therapies for advanced SM
  • Demonstrate greater confidence in their ability to
    • Care for patients with advanced SM
About the author

Author image

Matthew P. Giannetti

MD, Below are the relevant financial relationships:
Consultant or advisor for: Cogent Biosciences
Research funding from: Blueprint Medicines

Disclosed a conflict of interest. Their contributions are limited to non-clinical topics.

About the Peer Reviewer
Rating & reviews
5
0
4
0
3
0
2
0
1
0
Popular courses and webinars on CMEPEDIA


×